BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30476254)

  • 21. Prevalence of polyoma BK virus infection among living-donor renal transplant recipients.
    El Ansary M; Abd Elhamid S; Saadi G; Ismail W; Ibrahim N; Bahaa El-Din N; Alhsyek S
    Transpl Infect Dis; 2016 Aug; 18(4):529-37. PubMed ID: 27226063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunologic Clearance of a BK Virus-associated Metastatic Renal Allograft Carcinoma.
    Meier RPH; Muller YD; Dietrich PY; Tille JC; Nikolaev S; Sartori A; Labidi-Galy I; Ernandez T; Kaur A; Hirsch HH; McKee TA; Toso C; Villard J; Berney T
    Transplantation; 2021 Feb; 105(2):423-429. PubMed ID: 32091486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urine Donor-Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection.
    Chen XT; Chen WF; Li J; Deng RH; Huang Y; Yang SC; Chen PS; Jiang TY; Liu HT; Wang CX; Chen LZ; Qiu J; Huang G
    Front Immunol; 2020; 11():1763. PubMed ID: 32973745
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of low-level BK polyomavirus viremia on intermediate-term renal allograft function.
    Korth J; Widera M; Dolff S; Guberina H; Bienholz A; Brinkhoff A; Anastasiou OE; Kribben A; Dittmer U; Verheyen J; Wilde B; Witzke O
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29156086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.
    Höcker B; Schneble L; Murer L; Carraro A; Pape L; Kranz B; Oh J; Zirngibl M; Dello Strologo L; Büscher A; Weber LT; Awan A; Pohl M; Bald M; Printza N; Rusai K; Peruzzi L; Topaloglu R; Fichtner A; Krupka K; Köster L; Bruckner T; Schnitzler P; Hirsch HH; Tönshoff B
    Transplantation; 2019 Jun; 103(6):1224-1233. PubMed ID: 30130322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction.
    Dieplinger G; Everly MJ; Briley KP; Haisch CE; Bolin P; Maldonado AQ; Kendrick WT; Kendrick SA; Morgan C; Terasaki PI; Rebellato LM
    Transpl Infect Dis; 2015 Dec; 17(6):848-58. PubMed ID: 26442607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BK polyomavirus infection after renal transplantation: Surveillance in a resource-challenged setting.
    Bagchi S; Gopalakrishnan V; Srivastava SK; Upadhayay A; Singh G; Bhowmik D; Mahajan S; Dinda A; Agarwal SK
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28834032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glomerular Parietal Epithelial Cells Infection Is Associated With Poor Graft Outcome in Kidney Transplant Recipients With BK Polyomavirus-Associated Nephropathy.
    Chen XT; Yang SC; Chen WF; Li J; Deng SX; Qiu J; Fei JG; Deng RH; Chen YY; Chen PS; Huang Y; Wang CX; Huang G
    J Infect Dis; 2019 May; 219(12):1879-1886. PubMed ID: 30649366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New England BK consortium: Regional survey of BK screening and management protocols in comparison to published consensus guidelines.
    Gabardi S; Pavlakis M; Tan C; Francis J; Cardarelli F; Asch W; Bodziak K; Chobanian M; Gilligan H; Gohh R; Kung SC; Inker L; Martin S; Rodig N; Rossi A; Chandraker A
    Transpl Infect Dis; 2018 Dec; 20(6):e12985. PubMed ID: 30175491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
    Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM
    Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
    Hirsch HH; Randhawa PS;
    Clin Transplant; 2019 Sep; 33(9):e13528. PubMed ID: 30859620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk Factors for BK Polyoma Virus Treatment and Association of Treatment With Kidney Transplant Failure: Insights From a Paired Kidney Analysis.
    Thangaraju S; Gill J; Wright A; Dong J; Rose C; Gill J
    Transplantation; 2016 Apr; 100(4):854-61. PubMed ID: 27003098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Viral load and duration of BK polyomavirus viraemia determine renal graft fibrosis progression: histologic evaluation of late protocol biopsies.
    Reischig T; Kacer M; Hes O; Machova J; Nemcova J; Kormunda S; Pivovarcikova K; Bouda M
    Nephrol Dial Transplant; 2019 Nov; 34(11):1970-1978. PubMed ID: 31071208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia.
    Knight RJ; Graviss EA; Nguyen DT; Kuten SA; Patel SJ; Gaber L; Gaber AO
    Clin Transplant; 2018 Jun; 32(6):e13265. PubMed ID: 29676018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BK polyomavirus in the urine for follow-up of kidney transplant recipients.
    Brochot E; Descamps V; Handala L; Faucher J; Choukroun G; Helle F; Castelain S; François C; Duverlie G; Touzé A
    Clin Microbiol Infect; 2019 Jan; 25(1):112.e1-112.e5. PubMed ID: 30076973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia.
    Gabardi S; Ramasamy S; Kim M; Klasek R; Carter D; Mackenzie MR; Chandraker A; Tan CS
    Transpl Infect Dis; 2015 Aug; 17(4):536-43. PubMed ID: 25989423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BK polyomavirus nephropathy in two kidney transplant patients with distinct diagnostic strategies for BK virus and similar clinical outcomes: two case reports.
    Gouvêa ALF; Cosendey RIJ; Nascimento ALR; Carvalho FR; Silva AA; de Moraes HP; Rochael MC; Varella RB; Almeida SG; Almeida JR; Lugon JR
    J Med Case Rep; 2017 May; 11(1):146. PubMed ID: 28535782
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent cytomegalovirus glomerulitis and BK polyomavirus-associated nephropathy in a kidney allograft biopsy.
    Chikeka IO; Paulk A; Haririan A; Papadimitriou JC; Drachenberg CB
    Transpl Infect Dis; 2016 Apr; 18(2):247-50. PubMed ID: 26782090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.
    Halim MA; Al-Otaibi T; Gheith O; Zkaria Z; Mosaad A; Said T; Nair P; Nampoory N
    Exp Clin Transplant; 2014 Dec; 12(6):528-33. PubMed ID: 25489803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chk1 and the Host Cell DNA Damage Response as a Potential Antiviral Target in BK Polyomavirus Infection.
    Hainley LE; Hughson MS; Narendran A; Smith R; Arthur J; Hayner-Buchan A; Conti DJ; Lehman JM; Friedrich TD
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.